Use of perflubron as a new temporary vitreous substitute and manipulation agent for vitreoretinal surgery

Retina

Volumn 16, Issue 4, 1996, Pages 285-291

  Banker, Alay S ^a   Freeman, William R ^a,c   Vander, James F ^b   Flores Aguilar, Marisa ^a   Munguia, David ^a   Vander, James E ^d   Tasman, William ^d   Benson, William E ^d   Brown, Gary C ^d   McNamara, J Arch ^d   Belmont, Jonathan B ^d   Lucier, Alfred C ^d   Kleiner, Robert C ^d   Wong, Tien P ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WILLS EYE HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

PERFLUOROOCTYL BROMIDE;

ADOLESCENT; ADULT; AGED; ANTERIOR EYE SEGMENT; ARTICLE; CHILD; CILIARY DISK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RETINA DETACHMENT; RETINA TEAR; VISUAL ACUITY; VITRECTOMY; VITREORETINOPATHY; VITREOUS BODY;

EID: 8044224044     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-199616040-00002     Document Type: Article

References (29)

1. Chang S, Zimmerman NJ, Iwamoto T, et al. Experimental vitreous replacement with perfluorotributylamine. Am J Ophthalmol 1986; 102: 29-37.
2. Chang S. Low viscosity liquid fluorochemicals in vitreous surgery. Am J Ophthalmol 1987; 103:38-43.
3. Blinder KJ, Peyman GA, Paris CL, et al. Vitreon, a new perfluorocarbon. Br J Ophthalmol 1991; 75:240-244.
4. Coll GE, Chang S, Sun J, et al. Perfluorocarbon liquid in the management of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1995; 102:630-638.
5. Greve MD, Peyman GA, Mehta NJ, Millsap CM. Use of perfluoroperhydrophenanthrene in the management of posteriorly dislocated crystalline and intraocular lenses. Ophthalmic Surg 1993; 24:593-597.
6. Lewis H, Sanchez G. The use of perfluorocarbon liquids in the repositioning of posteriorly dislocated intraocular lenses. Ophthalmology 1993; 100:1055-1059.
7. Lewis H, Blumenkranz MS, Chang S. Treatment of dislocated crystalline lens and retinal detachment with perfluorocarbon liquids. Retina 1992; 12:299-304.
8. Terauchi H, Okinami S, Kosaki Z, et al. Experimental study on the effects of a replacement of the vitreous body with perfluorotributylamine on the rabbit eye. Nippon Ganka Gakkai Zasshi 1989; 93:294-301.
9. Nabih M, Peyman GA, Clark LC, et al. Experimental evaluation of perfluorophenanthrene as a high specific gravity vitreous substitute: a preliminary report. Ophthalmic Surg 1989; 20:286-293.
10. Chang S, Sparrow JR, Iwamoto T, et al. Experimental studies of tolerance to intravitreal perfluoro-n-octane liquid. Retina 1991; 11:367-374.
11. Eckardt C, Nicolai U, Winter M, Knop E. Experimental intraocular tolerance to liquid perfluorooctane and perfluoropolyether. Retina 1991; 11:375-384.
12. Flores-Aguilar M, Munguia D, Loeb E, et al. Intraocular tolerance of perfluoroctylbromide (perflubron). Retina 1995; 15:3- 13.
13. Mattrey RF, Long DM, Peck WW, et al. Perfluoroctylbromide as a blood pool contrast agent for liver, spleen, and vascular imaging in computed tomography. J Comput Assist Tomogr 1984; 8:739-744.
14. Peck WW, Mattrey RF, Slutsky RA, et al. Perfluoroctylbromide: acute hemodynamic effects, in pigs, of intravenous administration compared with the standard ionic contrast media. Invest Radiol 1984; 19:129-132.
15. Mattrey RF. Potential role of perfluoroctylbromide in the detection and characterization of liver lesions with cat-scan. Radiology 1989; 170:18-20.
16. Doslak MJ. Quantitative analysis of the insulating effect of silicone oil on the electroretinogram. Med Biol Eng Comput 1989; 27:254-259.
17. Long DM, Long DC, Mattrey RF, et al. An overview of perfluoroctylbromide - application as a synthetic oxygen carrier and imaging agent for x-ray, ultrasound and nuclear magnetic resonance. Biomater Artif Cells Artif Organs 1988; 16:411- 420.
18. Mattrey RF, Long DC. Potential role of perflubron in diagnostic imaging. Invest Radiol 1988; 23(suppl 1):S298-S301.
19. Mattrey RF, Scheible W, Gosink BB, et al. Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material. Radiology 1982; 145:759-762.
20. Kreiger AE, Lewis H. Management of giant retinal tears without scleral buckling: use of radical dissection of the vitreous base and perfluoro-octane and intraocular tamponade. Ophthalmology 1992; 99:491-497.
21. Darmakusuma IE, Glaser BM, Sjaarda RN, et al. The use of perfluoro-octane in the management of giant retinal tears without proliferative vitreoretinopathy. Retina 1994; 14:323-328.
22. Glaser BM, Carter JB, Kuppermann BD, Michels RG. Perfluoro-octane in the treatment of giant retinal tears with proliferative vitreoretinopathy. Ophthalmology 1991; 98:1613-1621.
23. Chang S, Ozmert E, Zimmerman NJ. Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy. Am J Ophthalmol 1988; 106:668-674.
24. Garcia RF, Flores-Aguilar, Quiceno M, et al. Results of rhegmatogenous retinal detachment repair in cytomegalovirus retinitis with and without scleral buckling. Ophthalmology 1995; 102:236-245.
25. Machemer R, Aaberg TM, Freeman HM, et al. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 1991; 112:159-165.
26. Riess JG, LeBlanc M. Blood Substitutes: Preparation, Physiology, and Medical Applications. Lowe KC, ed. Chichester, England: Ellis Horwood; 1988.
27. Geyer RP. Oxygen Carrying Blood Substitutes: Fifth International Symposium on Perfluorochemical Blood Substitutes. Mainz 1981.
28. LeBlanc M, Riess JG. Artificial blood substitutes based on perfluorochemicals. In: Banks RE, ed. Preparation, Properties and Industrial Applications of Organofluorine Compounds. Chichester: Ellis Horwood Limited; 1982:82-137.
29. Peyman GA, Schulman JA, Sull B. Perfluorocarbon liquids in Ophthalmology. Surv Ophthalmol 1995; 39:375-395.